|
|
|
|
LEADER |
02143ngm a2200361 i 4500 |
001 |
854f2d25-5872-4810-80e1-15c2bed5741c |
005 |
20230617000000.0 |
008 |
201104s2020 enk||| | |s v|eng d |
028 |
5 |
0 |
|a 5142
|b Henry Stewart Talks
|
035 |
|
|
|a (OCoLC-M)1224586873
|
035 |
|
|
|a (UkLoHST)4433
|
040 |
|
|
|a UkLoHST
|b eng
|c UkLoHST
|d CSt
|d UtOrBLW
|
100 |
1 |
|
|a Hale, Geoffrey
|u (Chief Executive Officer of mAbsolve Ltd., UK)
|4 spk
|? UNAUTHORIZED
|
245 |
1 |
0 |
|a Therapeutic antibodies
|h [electronic resource] /
|c Geoffrey Hale
|
260 |
|
|
|a London :
|b Henry Stewart Talks,
|c 2020
|
300 |
|
|
|a 1 online resource (1 streaming video file (49 min.) :
|b color, sound)
|
490 |
1 |
|
|a The immune system - key concepts and questions,
|x 2056-452X
|
500 |
|
|
|a Animated audio-visual presentation with synchronized narration
|
500 |
|
|
|a Title from title frames
|
505 |
0 |
|
|a Contents: Why antibodies are so useful as drugs -- Antibody therapy -- The development of monoclonal antibodies -- Genetic engineering -- The problem of unwanted immunogenicity -- The importance of affinity -- Examples of antibodies for treatment of cancer -- Examples of antibodies for treatment of immunological diseases
|
506 |
|
|
|a Access restricted to subscribers
|
538 |
|
|
|a Mode of access: World Wide Web
|
596 |
|
|
|a 22
|
650 |
|
0 |
|a Genetic engineering
|= ^A1021115
|
650 |
|
0 |
|a Immune system
|= ^A1079745
|
650 |
|
0 |
|a Immunoglobulins
|x Therapeutic use
|
650 |
|
0 |
|a Immunologic diseases
|= ^A1027191
|
650 |
|
0 |
|a Monoclonal antibodies
|x Therapeutic use
|= ^A2467696
|
650 |
|
2 |
|a Antineoplastic Agents, Immunological
|
650 |
|
2 |
|a Immune System Diseases
|x drug therapy
|
830 |
|
0 |
|a Henry Stewart talks
|p Biomedical life sciences collection.
|p Immune system - key concepts and questions.
|? UNAUTHORIZED
|
999 |
1 |
0 |
|i 854f2d25-5872-4810-80e1-15c2bed5741c
|l a13772672
|s US-CST
|m therapeutic_antibodies________________________________________________elect2020_______henryg________________________________________hale__geoffrey_____________________e
|
999 |
1 |
1 |
|l a13772672
|s ISIL:US-CST
|t VIS
|a SUL INTERNET
|b 13772672-1001
|c INTERNET RESOURCE
|d ASIS
|x SUL
|y 13772672-1001
|p UNLOANABLE
|